TNFRSF10B and renal carcinoma: Moreover, it has been shown that Par-4, along with TRAIL, increases death receptor-5 (DR5) expression and caspase activation, together with an enforced inactivation of anti-apoptotic XIAP and c-FLIP in renal cancer cells43.